Quick Takeaways
- ASBP - Aspire Biopharma Holdings, Inc. has 14 insiders with reported activity on this page.
- No net insider buy/sell flow is currently reported for the last year.
- Recent transaction rows are available for direct filing-level review.
- Info
- Insider Trading
- Financials
Insider Transactions Reported by 14 Insiders of Aspire Biopharma Holdings, Inc.
- Symbol
- ASBP, ASBPW on Nasdaq
- Location
- Estero, FL
What Changed
- No meaningful buy/sell imbalance is currently visible in the one-year window.
- Activity will update as new Forms 3/4/5 are filed.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Official SEC Source
There are no Buy or Sell transactions made by insiders since 06 Apr 2025
Aspire Biopharma Holdings, Inc. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Donald G. Fell | Director | $7,800 | $0 | 0% | Filing P/S | 04 Jun 2025 |
| Surendra K. Ajjarapu | Chief Executive Officer, Director, 10%+ Owner | Mixed | 18 Aug 2023 | |||
| Michael L. Peterson | Director | Mixed | 18 Aug 2023 | |||
| Howard A. Doss | Chief Financial Officer | Mixed | 18 Aug 2023 | |||
| Bruce L. Hack | Director | Mixed | 17 Feb 2022 | |||
| PowerUp Sponsor LLC | 10%+ Owner | Mixed | 18 Aug 2023 | |||
| Mayur Mansukhlal Doshi | Director | Mixed | 18 Aug 2023 | |||
| Peter Blacklow | Director | Mixed | 17 Feb 2022 | |||
| Jack Tretton | Chief Executive Officer, Director | Mixed | 17 Feb 2022 | |||
| Julie Uhrman | Director | Mixed | 17 Feb 2022 | |||
| Avinash R. Wadhwani | Director | Mixed | 18 Aug 2023 | |||
| Gabriel Schillinger | President | Mixed | 17 Feb 2022 | |||
| Michael J. Olson | Chief Financial Officer | Mixed | 17 Feb 2022 | |||
| Kyle Joseph Campbell | Director | Mixed | 16 May 2022 |
Recent Insider Transactions by Companies or Individuals for Aspire Biopharma Holdings, Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Donald G. Fell | ASBP | Common Stock, par value $0.0001 | Purchase | 110.5% | $4,095 | $0.3900 | 10,500 | 20,000 | 05 Jun 2025 | Direct |
| Donald G. Fell | ASBP | Common Stock, par value $0.0001 | Purchase | -34.4% | $4,095 | $0.3900 | -10,500 | 20,000 | 05 Jun 2025 | Direct |
| Donald G. Fell | ASBP | Common Stock, par value $0.0001 | Purchase | $3,705 | $0.3900 | 9,500 | 9,500 | 04 Jun 2025 | Direct | |
| Donald G. Fell | ASBP | Common Stock, par value $0.0001 | Purchase | -50% | $3,705 | $0.3900 | -9,500 | 9,500 | 04 Jun 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.